Sort
82,697 grants matching “vaccine development”
A Novel Engineered Probiotic for the Prevention of Clostridium Difficile Infection
$957,796Gary Fanger · Rise Therapeutics, Llc · R44 · FY2020 · AI
Integrated analysis of HBV-specific CD4 T cell and B cell responses to define their role in chronic hepatitis B and HBV functional cure.
$957,683Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2025 · AI
Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies
$957,548Laurent Karl Verkoczy · Applied Biomedical Science Institute · R01 · FY2021 · AI
Heritable immunization of the white-footed mouse reservoir of Lyme disease
$957,529Kevin Esvelt · Massachusetts Institute Of Technology · R01 · FY2021 · AI
Core 3: Biocontainment Research Support Services Core
$957,509Colin S. Duckett · Duke University · UC7 · FY2024 · AI
Active Immunization for Treating Methamphetamine Abuse
$957,317S. Michael Owens · Univ Of Arkansas For Med Scis · U01 · FY2008 · DA
Correlates of protective immunity to HCV and rational vaccine design: Project 3
$957,184Rama Rao Amara · Emory University · U19 · FY2023 · AI
Influence of viral and immune interventions on early events following oral SIV infection
$957,147Donald L Sodora · Seattle Children'S Hospital · R01 · FY2023 · DE
WaNPRC MACACA NEMESTRINA SPF BREEDING COLONY
$956,922University Of Washington · U24 · FY2003 · RR
Biostatistics Resource
$956,883Donald A Berry · University Of Tx Md Anderson Can Ctr · P30 · FY2010 · CA
Role of Gut and Skin Flora in the Control of Immune Responses
$956,847Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses
$956,757David E. Clements · Hawaii Biotech, Inc. · R44 · FY2016 · AI
Virus Clearance from the Central Nervous System
$956,718Douglas Craig Hooper · Thomas Jefferson University · R01 · FY2011 · AI
Demystifying the antiviral activity of the IgG3+ antibody response
$956,707Galit Alter · Massachusetts General Hospital · R37 · FY2016 · AI
A Novel Probiotic for the Treatment of Sjogren's Syndrome
$956,644Gary Fanger · Rise Therapeutics, Llc · R44 · FY2019 · DE
HPV, HIV and Oral Microbiota Interplay in Nigerian Youth (HOMINY)
$956,631Modupe Coker · University Of Pennsylvania · R01 · FY2024 · DE
Immunotherapeutics and vaccines against anthrax, plague and tularemia
$956,592Zheng W Chen · University Of Illinois At Chicago · U01 · FY2010 · AI
NOVEL HIV VACCINES
$956,491University Of Md Biotechnology Institute · P01 · FY2004 · AI
Real-time surveillance to support dynamic and predictive models of MDR/XDR TB
$956,346Megan B Murray · Brigham And Women'S Hospital · U19 · FY2011 · AI
Antibody-based Protection against Flavivirses
$956,340Michael S. Diamond · Washington University · R01 · FY2020 · AI
Genetically Attenuated Malaria Attenuated Whole Parasite Sporozoite Vaccine
$956,277Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2012 · AI
CD4 RESPONSES TO ANTIRETROVIRAL THERAPY (ART) ALONE OR ART WITH VACCINATION
$956,222Fred Valentine · New York University School Of Medicine · M01 · FY2008 · RR
Developmental Core (Core B)
$956,165Gwendolyn B. Scott · University Of Miami School Of Medicine · P30 · FY2021 · AI
Pathogenesis Of Enteric Viral Hepatitis
$956,113Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Task Order 9 Master Cell Bank for Chlamydia Trachoma Vaccine
$956,026Norman Kneteman · Advanced Bioscience Laboratories, Inc. · N01 · FY2013 · AI